BridgeBio Pharma, Inc.
SEC Filing List
BBIO CIK: 0001743881
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/18/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/17/2026 | ||
| SCHEDULE 13D/A | Broadridge Financial Solutions, Inc. /fa | 08/17/2026 | |||
| 8-K | Current report filing | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 08/17/2026 | |
| 424B7 | Prospectus filed pursuant to Rule 424(b)(7) | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 08/14/2026 | |
| 8-K | Current report filing | Bridgebio Pharma, Inc. | 08/10/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Bridgebio Pharma, Inc. | 08/10/2026 | ||
| SCHEDULE 13G/A | BARNES & THORNBURG LLP /fa | 08/03/2026 | |||
| 4 | Statement of changes in beneficial owner... | Apuli Maricel | goodwin procter llp /fa | 08/03/2026 | |
| SCHEDULE 13G/A | 07/27/2026 | ||||
| No record found. | |||||
| Load More | |||||
